AMC
TGTX icon

Asset Management Corp’s TG Therapeutics TGTX Stock Holding History

Asset Management Corp’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,000
Closed -$182K – 202
2021
Q3 		$233K Hold
7,000
– – 0.12% 160
2021
Q2 		$272K Hold
7,000
– – 0.16% 131
2021
Q1 		$337 Buy
+7,000
New +$336K 0.14% 128

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Asset Management Corp's TGTX Position: Q4 2021 in Review

Asset Management Corp sold out of TG Therapeutics (TGTX) in Q4 2021, closing a stake of 7,000 shares — an estimated $182K sold.

Asset Management Corp first reported a position in TGTX in Q1 2021 and held it in 3 quarters. The position peaked at $272K in Q2 2021. 194 funds tracked by Wall St. Rank hold TGTX as of Q4 2021.

  • Asset Management Corp reported no remaining TG Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Asset Management Corp sold 7,000 TG Therapeutics shares in Q4 2021, an estimated $182K.
  • Asset Management Corp first reported a position in TG Therapeutics in Q1 2021 and held it in 3 quarters.
  • Asset Management Corp's TG Therapeutics position peaked at $272K in Q2 2021.
  • 194 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2021.

Based on Asset Management Corp's 13F filing for Q4 2021, filed 25 Jan 2022.